LLLopa Leach

Lopa Leach

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lopa Leach has a total of 216 co-authors. Here are the top co-authors by number of shared publications:

  • J. Anthony Firth

    St. Mary’s Hospital Medical School, Imperial College of Science, Technology and Medicine

    4 shared publications
  • Bryan M. Eaton

    Department of Anatomy & Cell Biology, St. Mary's Hospital Medical School, Imperial College of Science, Technology & Medicine, Norfolk Place, London W2 1PG; and Academic Department of Obstetrics & Gynaecology, Charing Cross & Westminster Medical School, Chelsea & Westminster Hospital, 369 Fulham Road, London SW10 9NH, United Kingdom

    3 shared publications
  • Igor L. Chernyavsky

    University of Manchester

    3 shared publications
  • J.A. Firth

    Leukocyte Biology, Division of Biomedical Sciences, Imperial College School of Medicine, London

    3 shared publications
  • P. Clark

    3 shared publications
  • Paul Brownbill

    Maternal and Fetal Health Research Centre University of Manchester Manchester UK

    3 shared publications

Latest Publications

  • Open Access

    Septal venous drainage facilitates oxygen-transfer kinetics in the human placenta

    by Lopa Leach, Dimitrios Amanitis, Fenia Deligianni, Reem Abuhaimed, Hatoon Alkeraim

    Efficient materno–fetal oxygen transfer depends on continual renewal of oxygen gradients in placental intervillous spaces (lacunae), where fetal capillaries, encased in chorionic villi, float freely in maternal blood. The pathways for maternal venous drainage from these lacunae are poorly defined. Combining structural analysis of term placentae with near-physiological ex vivo dual-perfusion, we identified EphB4⁺ veins within decidual septa as an additional important discrete maternal exit pathway. In normal placentae, with septal veins, umbilical venous oxygen peaked (Pr = 9.8%) within 2.8 min (Tp). In small-for-gestational-age and high-BMI pregnancy groups — with elevated stillbirth risk — septal veins were absent with Tp > 10 min, although peak oxygenation was eventually reached. Multivariate analysis associated septal-vein presence with oxygen-transfer kinetics and fetal growth. Continual renewal of intervillous oxygen gradients, not maximal transfer capacity alone, constrains placental efficiency. Absent septal venous drainage narrows the margin of fetal oxygen reserves, increasing susceptibility to stillbirth.

  • Open Access

    Inclusivity and Decolonisation of the Post-Graduate Public Health Curriculum: Reflections from a Student-Led Approach

    by G. Carleton-Boylan, S. Crossley, P. Siebert, N. Ajanaku, A. Iqbal, A. John, S. Sandhu, C. Williams, L. Leach, R. Patel, et al.


  • Open Access

    Compromised barrier integrity of human feto-placental vessels from gestational diabetic pregnancies is related to downregulation of occludin expression

    by Stephany Daniela Villota, Maria Toledo-Rodriguez, Lopa Leach

    Aims/hypothesis: Reduced occupancy of junctional occludin is a feature of human placental vessels in the diabetic milieu. However, the functional consequence of this and whether this loss is due to differential expression of occludin splice variants is not known. Our study aimed to investigate the effects of gestational diabetes mellitus (GDM), and its treatment, on endothelial junctional integrity, gene and protein expression of occludin splice variants, and potential regulation of expression by microRNAs (miRNAs). Methods: Term placentas were obtained from normal pregnancies (n = 21), and pregnancies complicated by GDM where glucose levels were controlled by diet (n = 11) or metformin (n = 6). Gene and microRNA (miRNA) expression were determined by quantitative real-time PCR; protein expression by immunoblotting; endothelial junctional occupancy by fluorescence microscopy and systematic sampling; and paracellular leakage by perfusion of placental microvascular beds with 76 Mr dextran. Transfection studies of miRNAs that target OCLN were performed in HUVECs, and the trans-endothelial electrical resistance and tracer permeability of the HUVECs were measured. Results: All three predicted OCLN gene splice variants and two occludin protein isoforms were found in human placental samples. In placental samples from diet-controlled GDM (d-GDM) pregnancies we found a lower percentage of conduit vessels showing occludin immunoreactivity (12%, p < 0.01), decreased levels of the fully functional occludin isoform-A protein (29%), and differential gene expression of OCLN variant 2 (33% decrease), variant 3 (3.3-fold increase). These changes were not seen in samples from the group with metformin-controlled GDM. In d-GDM placentas, increased numbers of conduit microvessels demonstrated extravasation of 76 Mr dextran (2.0-fold). In d-GDM expression of one of the five potential miRNAs targeting OCLN, miR-181a-5p, expression was 2.1-fold that in normal pregnancies. Experimental overexpression of miR-181a-5p in HUVECs from normal pregnancies resulted in a highly significant downregulation of OCLN variant 1 (69%) and variant 2 (46%) gene expression, with decreased trans-endothelial resistance (78%) and increase in tracer permeability (1.3-fold). Conclusions/interpretation: Downregulation of expression of OCLN variant 2 and the fully functional occludin isoform-A protein are a feature of placentas in d-GDM pregnancies. These may be behind the loss of junctional occludin and the increased extravasation of exogenous dextran observed. miR-181a-5p was in part responsible for the downregulation of occludin in placentas from d-GDM pregnancies. Induced overexpression of miR-181a-5p compromised the integrity of the endothelial barrier. Our data suggest that, despite good glucose control, the adoption of lifestyle changes alone during a GDM pregnancy may not be enough to prevent an alteration in the expression of occludin and the subsequent functional consequences in placentas and impaired vascular barrier function in offspring.


  • Open Access

    The haemodynamics of the human placenta in utero

    by Neele S Dellschaft, George Hutchinson, Simon Shah, Nia W Jones, Chris Bradley, Lopa Leach, Craig Platt, Richard Bowtell, Penny A Gowland

    We have used magnetic resonance imaging (MRI) to provide important new insights into the function of the human placenta in utero. We have measured slow net flow and high net oxygenation in the placenta in vivo, which are consistent with efficient delivery of oxygen from mother to fetus. Our experimental evidence substantiates previous hypotheses on the effects of spiral artery remodelling in utero and also indicates rapid venous drainage from the placenta, which is important because this outflow has been largely neglected in the past. Furthermore, beyond Braxton Hicks contractions, which involve the entire uterus, we have identified a new physiological phenomenon, the ‘utero-placental pump’, by which the placenta and underlying uterine wall contract independently of the rest of the uterus, expelling maternal blood from the intervillous space.


  • Open Access

    The haemodynamics of the human placenta in utero

    by Neele S. Dellschaft, George Hutchinson, Simon Shah, Nia W. Jones, Christopher Bradley, Lopa Leach, Craig Platt, Richard Bowtell, Penny A. Gowland

    We have used MRI to provide important new insights into the function of the human placentain utero. We have measured slow net flow and high net oxygenation in the placentain vivo, which are consistent with efficient delivery of oxygen from mother to fetus. Our experimental evidence substantiates previous hypotheses on the effects of spiral artery remodellingin utero, and also indicates rapid venous drainage from the placenta, which is important since the outflow has been largely neglected in the past. Furthermore, beyond Braxton Hicks contractions, which involve the entire uterus, we have identified a new physiological phenomenon, the ‘utero-placental pump’, by which the placenta and underlying uterine wall contract independently of the rest of the uterus, expelling maternal blood from the intervillous space.


  • Open Access

    Impaired vasocontractile responses to adenosine in chorionic vessels of human term placenta from pregnant women with pre-existing and gestational diabetes

    by Azlina A Razak, Lopa Leach, Vera Ralevic

    Background: There is clinical and experimental evidence for altered adenosine signalling in the fetoplacental circulation in pregnancies complicated by diabetes, leading to adenosine accumulation in the placenta. However, the consequence for fetoplacental vasocontractility is unclear. This study examined contractility to adenosine of chorionic vessels from type 1 diabetes mellitus, gestational diabetes mellitus and normal pregnancies. Methods: Chorionic arteries and veins were isolated from human placenta from normal, gestational diabetes mellitus and type 1 diabetes mellitus pregnancies. Isometric tension recording measured responses to adenosine and the thromboxane A2 analogue U46619 (thromboxane A2 mediates fetoplacental vasoconstriction to adenosine). Adenosine and thromboxane prostanoid receptor protein expression was determined by immunoblotting. Results: Adenosine elicited contractions in chorionic arteries and veins which were impaired in both gestational diabetes mellitus and type 1 diabetes mellitus. Contractions to potassium chloride were unchanged. Adenosine A2A and A2B receptor protein levels were not different in gestational diabetes mellitus and normal pregnancies. Contractions to U46619 were unaltered in gestational diabetes mellitus arteries and increased in type 1 diabetes mellitus arteries. Overnight storage of vessels restored contractility to adenosine in gestational diabetes mellitus arteries and normalized contraction to U46619 in type 1 diabetes mellitus arteries. Conclusion: These data are consistent with the concept of aberrant adenosine signalling in diabetes; they show for the first time that this involves impaired adenosine contractility of the fetoplacental vasculature.


  • Open Access

    IFPA meeting 2017 workshop report: Clinical placentology, 3D structure-based modeling of placental function, placental bed, and treating placental dysfunction

    by Ganesh Acharya, John Aplin, Paul Brownbill, Judith Bulmer, Graham Burton, Larry Chamley, Igor Chernyavsky, Alys Clark, Sally Collins, Elizabeth Cottrell, et al.


  • Open Access

    Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherin

    by Vincent Pang, David O. Bates, Lopa Leach

    The human placenta nourishes and protects the developing foetus whilst influencing maternal physiology for fetal advantage. It expresses several members of the vascular endothelial growth factor (VEGF) family including the pro-angiogenic/pro-permeability VEGF-A165a isoform, the anti-angiogenic VEGF-A165b, placental growth factor (PIGF) and their receptors, VEGFR1 and VEGFR2. Alterations in the ratio of these factors during gestation and in complicated pregnancies have been reported; however, the impact of this on feto-placental endothelial barrier integrity is unknown. The present study investigated the interplay of these factors on junctional occupancy of VE-cadherin and macromolecular leakage in human endothelial monolayers and the perfused placental microvascular bed. Whilst VEGF-A165a (50 ng/ml) increased endothelial monolayer albumin permeability (P0.05) or PlGF (P>0.05) did not. Moreover, VEGF-A165b (100 ng/ml; P0.05) inhibited VEGF-A165a-induced permeability when added singly. PlGF abolished the VEGF-A165b-induced reduction in VEGF-A165a-mediated permeability (P>0.05); PlGF was found to compete with VEGF-A165b for binding to Flt-1 at equimolar affinity. Junctional occupancy of VE-cadherin matched alterations in permeability. In the perfused microvascular bed, VEGF-A165b did not induce microvascular leakage but inhibited and reversed VEGF-A165a-induced loss of junctional VE-cadherin and tracer leakage. These results indicate that the anti-angiogenic VEGF-A165b isoform does not increase permeability in human placental microvessels or HUVEC primary cells and can interrupt VEGF-A165a-induced permeability. Moreover, the interplay of these isoforms with PIGF (and s-flt1) suggests that the ratio of these three factors may be important in determining the placental and endothelial barrier in normal and complicated pregnancies.


  • An international network (PlaNet) to evaluate a human placental testing platform for chemicals safety testing in pregnancy

    by Paul Brownbill, Igor Chernyavsky, Barbara Bottalico, Gernot Desoye, Stefan Hansson, Gerry Kenna, Lisbeth E. Knudsen, Udo R. Markert, Nicola Powles-Glover, Henning Schneider, et al.